Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Deltex Medical wins largest NHS order for two years

The hospital in the south-east of England has bought six CardioQ-ODM+ monitors and oesophageal probes
picture of surgeons working
NHS work is picking up again suggests Deltex

Deltex Medical Group plc (LON:DEMG) has won its most significant order from a NHS hospital for Oesophageal Doppler Monitoring equipment for over two years.

The hospital in the south-east of England has bought six CardioQ-ODM+ monitors and oesophageal probes in a  purchase worth £30,000.

Its doctors demanded a replacement to equipment bought in 2013 through a NHS national  programme.

While the order was not large enough to affect forecasts this year, it does reflect a generally improving UK performance in the second half of the year to date said Deltex.

Ewan Phillips chief executive, said it was encouraging that it was doctors insisting on its equipment.

Deltex has been hard hit by the cash crisis affecting the NHS but Phillips said today’s order was further evidence that, for the company anyway, the situation may be improving.

“Excellent results from the largest ever randomised controlled trial of ODM in June and the further presentation in July of a trial from a major NHS hospital confirming better comparative outcomes from using ODM during surgery," had also boosted sentiment, he added.

View full DEMG profile View Profile

Deltex Medical Group plc Timeline

Newswire
May 31 2017

Related Articles

1528305384_Untitled-design-(3).jpg
June 06 2018
Ventripoint received key FDA approval to sell the device with the four-chamber heart analysis last month
cholesterol on a dial
September 24 2018
"The formation of ProBiotix Health and appointment of Adam Reynolds as chairman continues a successful strategy of building value in each division which is materialised by forming separate legal entities and taking them to a public listing,” said chief executive Stephen O’Hara
1511901712_biotech_517925923.jpg
November 29 2017
The company has developed a "unique and superior pressure" cycling technology (PCT), says Zacks.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use